Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
139 participants
OBSERVATIONAL
2020-08-01
2021-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
RALE Versus CORADS/CT-Severity Score in COVID-19
NCT05047653
Rapid Diagnosis of Patients With Chest Pain During the Covid-19 Outbreak (My-ABCDE)
NCT05394038
Lung Ultrasound Findings in Patients With COVID-19 in a UK ED
NCT05065827
Echocardiography in Critically-ill Patients With COVID-19 Pneumonia
NCT04414410
Construction of a Composite Clinical-echo Score Predictive of a Risk of Short-term Aggravation of Respiratory Impairment in Patients Suspected of Covid-19
NCT04370249
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having had received invasive ventilation
* Having had received at least one chest radiograph under invasive ventilation
* Confirmed novel coronavirus diseases (COVID-19)
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Bari Aldo Moro
OTHER
Mahidol University
OTHER
Universitair Ziekenhuis Brussel
OTHER
Chonburi hospital
OTHER_GOV
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Marcus J. Schultz
Prof. M.J. Schultz, MD PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marcus J. Schultz, Prof.
Role: PRINCIPAL_INVESTIGATOR
Amsterdam University Medical Centers, location 'AMC'
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Amsterdam UMC location AMC
Amsterdam, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RALE-COVID
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.